热门资讯> 正文

Dyne Therapeutics股票发行价为350美元

2025-12-10 14:39

Dyne Therapeutics (DYN) priced an upsized underwritten public offering of 18.98M shares at af $18.44 per share.
The gross proceeds are expected to be $350.0 million.
The offering is expected to close on or about December 11, 2025
The underwriters have a 30-day option to purchase up to an additional 2.85M shares.

More on Dyne Therapeutics

Dyne Therapeutics, Inc. (DYN) Discusses Positive Topline Results From DELIVER Registrational Expansion Cohort in Duchenne Muscular Dystrophy Transcript
Dyne Therapeutics, Inc. (DYN) Discusses Positive Topline Results From DELIVER Registrational Expansion Cohort in Duchenne Muscular Dystrophy - Slideshow
Dyne: Accelerated Approval Established Endpoint Sets Stage For DM1 Data In Mid-2026
Dyne Therapeutics announces $300M proposed public offering
Dyne, PepGen jump as potential beneficiaries of Novartis/Avidity deal

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。